Influenza 2025-2026 and 2026-2027

Here are the flu vaccines available for 2026-2027:

Manufacturer Trade Name Age range Type
AstraZeneca FluMist (LAIV3) 2-49 Live attenuated nasal spray
GSK Fluarix (IIV3) 0.5+ Inactivated, egg based
GSK FluLaval (IIV3) 0.5+ Inactivated, egg based
Moderna mFlusiva 50+ mRNA
Sanofi Flublok (RIV3) 9+ Recombinant hemagglutinin, 3x antigen
Sanofi Fluzone (IIV3) 0.5+ Inactivated, egg based
Sanofi Fluzone High-Dose (HD-IIV3) 65+ Inactivated, egg based, 4x antigen
CSL Sequirus Fluad (aIIV3) 65+ Inactivated, egg based, adjuvanted
CSL Sequirus Flucelvax (ccIIV3) 0.5+ Inactivated, dog cell based

In various trials and studies, mFlusiva, FluBlok, Fluzone High-Dose, and Fluad have been found to be more effective (typically by around 30%) against flu in older adults than the usual (IIV3) vaccines.

People with egg allergies can look for non-egg vaccines, which are readily available (Flucelvax is commonly found at Costco, and mFlusiva and Flublok are non-egg based options for older adults wanting the stronger vaccines).

The targeted flu strains for the 2026-2027 season:

Note that flu vaccines have been trivalent rather than quadrivalent since a few years ago, due to one of the targeted influenza B strains going extinct due to COVID-19 related measures (social distancing, masking, reduction of indoor activities, etc.) being effective against influenza.